Related by context. All words. (Click for frequent words.) 71 GATTEX ® 69 Current Controlled Trials 68 dotMobi domains 68 http:/www.clinicaltrials.gov 68 ThermoDox ® clinical 67 Recurrent Glioblastoma 67 ISRCTN# 66 number NCT# ClinicalTrials.gov 66 BR.# 66 FundingPost Event Calendar 66 PI3K/Akt pathway inhibitor 65 Clinicaltrials.gov 65 tramiprosate Alzhemed TM 65 relapsed MM 65 Fx #A 65 identifier NCT# 65 Zerenex Phase 64 GATTEX ™ 64 alvespimycin 64 ClinicalTrials.gov Identifier NCT# 64 NCT# 64 Tramiprosate ALZHEMED TM 64 PANVAC VF 64 treatment naive genotype 64 Phase Ib IIa 64 refractory chronic lymphocytic 64 Phase #b/#a clinical 64 Matrix Phase 2b 64 Initiates Phase II 64 BRIM3 63 INSPIRE Trial Phase III 63 pharmacogenomic translational research 63 www.ClinicalTrials.gov 63 Pivotal Phase III 63 Arzerra TM 63 please visit http:/www.sunesis.com 63 GERD migraine headaches 63 Initiates Phase III 63 R vitespen 63 rALLy clinical trial 63 including eniluracil ADH 63 brivanib 63 Optelecom NKF periodic 63 toenail onychomycosis 62 phase III isavuconazole 62 myelodysplastic myeloproliferative diseases 62 BRIM2 62 MAGE A3 ASCI 62 www.clinicaltrials.gov 62 Cloretazine ® 62 GVAX ® 62 REVIVE Diabetes 62 Bayer HealthCare Onyx Pharmaceuticals 62 dyslipidemia hypertension diabetes 62 Completes Patient Enrollment 62 ClinicalTrials.gov identifier NCT# 62 OvaRex ® MAb 62 intravenous RSD# 62 lintuzumab SGN 62 Initiates Enrollment 62 Phase III randomized controlled 62 Cloretazine 62 TM pralatrexate injection 62 Phase III multicenter 62 multicenter Phase III 62 Evoltra ® 62 ID NCT# 62 recurrent metastatic 62 XL# anticancer compounds 62 Telik logo TELINTRA 62 clinicaltrials.gov 62 RELOVAIR ™ 62 www.allos.com 62 Crofelemer budesonide foam 62 Phase III Pivotal 62 lorcaserin Phase 62 Phase IIIb 62 Phase Ib II 62 Initiate Phase 62 relapsing remitting MS RRMS 62 TASKi2 62 BOS periodic 62 ALN VSP Phase 62 visit http:/www.clinicaltrials.gov/ 62 Triapine R 62 galiximab 62 GetGoal Phase III 61 Phase IIIb clinical 61 cutaneous T 61 Veronate R 61 unique alkylating agent 61 commercialize CorMedix drug 61 registrational Phase 61 bortezomib Velcade R 61 PDX pralatrexate 61 approved incretin mimetic 61 CHAMPION PCI 61 Aryplase 61 novel therapeutic antibodies 61 Boxed Warnings 61 tumors GIST 61 Specifid 61 www.cellgenesys.com 61 investigational oral hepatitis C 61 randomized controlled multicenter 61 novel emulsion formulation 61 uterine fibroid induced 61 patientswith 61 reduce serum phosphate 61 GENASIS clinical 61 www.cerus.com 61 recurrent glioblastoma multiforme GBM 61 blinded randomized placebo controlled 61 non nucleoside inhibitor 61 metastatic pancreatic 61 Proellex TM 61 Cloretazine R VNP#M 60 acyclovir Lauriad R 60 oral talactoferrin 60 rALLy 60 budesonide MMX Phase III 60 ALN HPN 60 Hedgehog Pathway Inhibitor 60 catheter occlusion 60 kidney urologic 60 PLX STROKE targeting 60 See WARNINGS 60 trastuzumab DM1 T DM1 60 recombinant PSMA vaccine 60 website http:/www.celsion.com 60 Second Pivotal Phase 60 http:/www.vivus.com 60 novel VDA molecule 60 papillary renal cell carcinoma 60 forodesine 60 www.cardiome.com 60 HEPLISAV TM hepatitis B 60 Budesonide foam crofelemer 60 targeting miR 60 ADVANCE ILLUMINATE 60 non nucleoside HCV 60 systemic Phase 1b 60 ThermoDox R 60 oral ridaforolimus 60 albiglutide 60 placebo controlled Phase III 60 phase IIb study 60 metastatic GIST 60 imetelstat GRN#L 60 Saxagliptin 60 discontinued Viread 60 sitaxsentan sodium 60 MKC# MT 60 Nexavar prescribing 60 www.anthera.com 60 CALGB # [002] 60 Xeloda ® 60 opioid induced bowel dysfunction 60 MCSP respectively 60 pralatrexate injection folate analogue 60 essential thrombocythemia ET 60 GVAX R 60 TELCYTA TM TLK# 60 Successfully Completes Phase 60 RhuDex TM 60 deCODE ProstateCancer TM 60 Initiates Clinical Trial 60 bevirimat Study 60 www.syntapharma.com 60 Maven Semantic 60 myocardial infarction ventricular fibrillation 60 evaluating mipomersen 60 severe hypercholesterolemia 59 inhaled AAT 59 relapsed refractory multiple myeloma 59 telomerase therapeutic 59 systemic juvenile idiopathic 59 www.portlandalliance.com 59 R lenalidomide 59 www.adeonapharma.com 59 dose intramuscular 59 Phase 1b clinical trials 59 unresectable recurrent 59 http:/www.curagen.com 59 Phase III ThermoDox 59 Receives Orphan Drug 59 Commences Phase 59 TRIOLEX HE# APOPTONE HE# 59 Pyridorin TM 59 Initiates Clinical 59 humanized therapeutic 59 LungAlert TM 59 DEB# 59 Kit CD# positive 59 ClinicalTrials.gov 59 Initiate Phase II 59 www.micromet inc.com 59 neuropathic pain spasticity 59 chronic thromboembolic pulmonary 59 hypereosinophilic syndrome 59 lexidronam injection 59 CTAP# 59 www.telik.com 59 asthma rheumatoid arthritis 59 Tectin TM 59 initiated Phase Ib 59 acetonide FA 59 bone marrow reticulin deposition 59 Combination REOLYSIN R 59 please visit www.advaxis.com 59 HIV coinfected 59 resectable pancreatic cancer 59 stage IIIb IV 59 Oral Insulin Capsule 59 http:/www.idenix.com 59 lumiliximab 59 oxypurinol 59 dose escalation phase 59 www.sciclone.com 59 vomiting fever headache 59 http:/www.businesswire.com/ 59 EOquin TM 59 CYT# potent vascular disrupting 59 Sabah Aboud 59 vaccine GMK 59 IIb clinical trial 59 receptor tyrosine kinase inhibitor 59 thetreatment 59 phase IIb clinical 59 IMPACT DCM 59 hoFH 59 Begins Clinical Trial 59 www.keithley.com events semconfs 59 Brentuximab Vedotin SGN 59 Enzastaurin 59 Testosterone MDTS ® 59 www.bioalliancepharma.com 59 assessing T DM1 59 FOLOTYN ® 59 metastatic dermatofibrosarcoma protuberans DFSP 59 Please visit www.antisoma.com 59 zoledronic acid Reclast 59 Initiates Phase 2b 59 Qnexa TM 59 structure infections ABSSSI 59 Granted Orphan Drug 59 recurrent metastatic ovarian cancer 59 recurrent glioblastoma multiforme 59 EmbraceAC 59 Aeolus Pharmaceuticals Announces 59 Targretin capsules 59 smoldering multiple myeloma 59 REMINYL ® 59 Nissan Pathfinder license plates 59 Submits Response 59 Fibrillex TM 59 phase Ib 59 CEL SCI Phase III 59 Stage IIIb 59 EXPLORE Xa 59 CCR5 mAb 59 Solazed 59 collagen vascular 59 vapreotide acetate 59 PROMACTA CARES 59 Peginterferon alfa 2b 59 oncolytic virus therapies 59 SafeNet periodic 59 refractory gastrointestinal stromal 58 Amgen Neulasta R 58 PF # [002] 58 3 registrational trial 58 REGN# 58 Empatic ™ 58 www.micromet.com 58 AAG geldanamycin analog 58 Bacille Calmette Guérin BCG 58 crizotinib PF # 58 Begins Dosing 58 www.sanofi aventis.us 58 www.novartis.com 58 www.oxigene.com 58 humanised monoclonal antibody 58 deCODE AF TM 58 clinicaltrials 58 clevudine 58 CAMMS# 58 Phase III placebo controlled 58 GENASIS 58 R sorafenib tablets 58 Pharmos pipeline 58 sorafenib tablets 58 http:/www.gpc-biotech.com 58 ZACTIMA 58 ruxolitinib 58 OvaRex R 58 PEARL SC 58 potent triglyceride lowering 58 huN# DM1 58 hyaluronidase enzyme 58 Phase IIb III 58 mertansine 58 ENABLE Phase 2 58 metastatic castrate resistant 58 ZYBRESTAT TM 58 proprietary radiolabeled monoclonal 58 Completes Enrollment 58 refractory gout 58 sex offender Letourneau 58 anti botulism antibody 58 JAK#/JAK# inhibitor CYT# 58 Temodar ® 58 RECORD1 58 Submits IND 58 Phase lll 58 Oral Fingolimod 58 Amgen Neulasta ® 58 PROSTVAC ® 58 ZOLINZA 58 GRNVAC1 58 IMiDs ® 58 phase IIIb 58 Tykerb lapatinib 58 EDEMA3 58 albiglutide currently 58 oral nucleoside analogue 58 VEGFR2 inhibitor 58 Nanobody R 58 NOX E# 58 Vascular Disrupting Agent 58 Phase 2b Clinical Trial 58 headache nasopharyngitis 58 BrachySil TM 58 Presents Positive 58 LymphoStat B belimumab 58 opioid naive 58 budesonide foam 58 UPLYSO 58 aerosolized AAT 58 squamous non 58 include ColorectAlert TM 58 Dacogen injection 58 pan histone deacetylase 58 Phase IIb clinical trials 58 treatment naïve genotype 58 Forodesine HCl 58 TASKi3 58 midstage clinical 58 trial evaluating Prochymal 58 azilsartan medoxomil 58 Severe Sepsis 58 CIMZIA TM certolizumab pegol 58 www.vivus.com 58 recurrent malignant glioma 58 UVIDEM 58 Pegloticase 58 demonstrated antitumor activity 58 Diabetic Nephropathy 58 GW# [003] 58 Emtriva Viread 58 evaluating T DM1 58 dasatinib Sprycel ® 58 Anti PlGF 58 Plaque Psoriasis 58 AVN# Phase 58 Manja Bouman CEO 58 APEX PD 58 Therapeutic Competitors companiesandmarkets.com adEgemonye 58 CONQUER OB 58 Tumor Response 58 RhuDex ™ 58 hypoparathyroidism 58 vinflunine 58 confirmatory clinical 58 delivers fluocinolone acetonide FA 58 intravenous belinostat 58 retinal vein occlusion induced 58 Tesmilifene 58 leukemia multiple myeloma 58 sapacitabine CYC# 58 http:/www.optimerpharma.com 58 OncoVex 58 pioglitazone hydrochloride 58 immune globulin intravenous 58 midstage trials 58 Phase 2b monotherapy 58 Randomized Phase II 58 evaluating Vectibix 58 Acute Myeloid Leukemia AML 58 HeFH 58 fosbretabulin 58 Cutaneous T 58 trauma malignant tumors 58 ChemGenex Pharmaceuticals Limited 58 Acute myeloid leukemia 58 Inc. Nasdaq ALSE 57 DIRECT Trial 57 metastatic colorectal carcinoma 57 naïve HCV 57 Files IND 57 Phase III ADT 57 YOUR LOCAL ANIMAL SHELTER 57 Urocidin TM 57 BIOV 57 Xcellerated T Cells 57 progressive metastatic prostate 57 Receives Orphan Drug Designation 57 Acute myelogenous leukemia 57 metastatic renal 57 Entereg R 57 #-# www.pardeehospital.org 57 evaluating Prochymal 57 www.cellceutix.com 57 Hepsera adefovir dipivoxil 57 www.hceda.org 57 aflibercept VEGF Trap 57 LymphoStat B TM 57 refractory metastatic 57 Canvaxin TM 57 phase IIb trial 57 systemic ALCL 57 http:/www.unigene.com 57 selective phosphodiesterase 57 Phase 2b RESTORE CLI 57 Triapine 57 radiation sensitizer 57 Nonalcoholic fatty liver 57 randomized Phase IIb 57 biliary tract cancer 57 YONDELIS 57 XL# SAR# 57 Amoxicillin PULSYS Phase III 57 CA9 SCAN 57 OPT CHF 57 Prodarsan R 57 refractory colorectal cancer 57 solid tumors ZYBRESTAT 57 www.morrishospital.org 57 receiving chemoradiation therapy 57 Azmacort R 57 primary humoral immunodeficiency 57 lymphoma multiple myeloma 57 MAGE A3 protein 57 IMPACT DCM clinical 57 lupus renal disease 57 OVATURE 57 commercialize deforolimus 57 EOquin TM phase 57 ongoing Phase 1b 57 rindopepimut 57 CTAP# Capsules 57 Xelox 57 iii GTx 57 management biostatistical analysis 57 PORxin TM platforms 57 orally administered inhibitor 57 multicentre prospective 57 Achieves Primary Endpoint 57 Prednisone Against Refractory 57 Phase Ib clinical 57 Arzerra ofatumumab 57 Syncria albiglutide 57 refractory CLL 57 http:/www.hematology.org 57 Raptiva ® 57 Archexin 57 please visit http:/www.avastin.com 57 www.amarincorp.com 57 Soft Tissue Sarcoma 57 Dosa suffers 57 hypoxia activated prodrug 57 ChronVac C 57 www.alexionpharma.com 57 SNT MC# 57 decompensated liver disease 57 Troxatyl 57 advanced medullary thyroid 57 Lenocta TM 57 ara C 57 Hepatocellular Carcinoma HCC 57 neratinib 57 Heterozygous Familial Hypercholesterolemia 57 metastatic bladder 57 http:/www.questdiagnostics.com 57 mild hepatic impairment 57 bladder ovarian 57 phase III ACCLAIM 57 uremic pruritus 57 www.cambrex.com 57 www.accentia.net 57 LibiGel ® 57 Full Prescribing Information 57 XL# XL# XL# XL# 57 Hsp# Inhibitor 57 ViaDerm hPTH #-# 57 compound INCB# 57 SinuNase ™ 57 successfully commercialize Iluvien 57 opioid bowel dysfunction 57 anti PlGF 57 RTP #i 57 atherosclerosis rheumatoid arthritis 57 refractory NSCLC 57 RhuDex R 57 Virulizin ® 57 CAELYX 57 ANCHOR trial 57 relapsed leukemia 57 GOUT 57 LUX Lung 57 hepatorenal syndrome 57 oropharyngeal candidiasis OPC 57 alpha antagonist 57 Pafuramidine 57 www.xoma.com 57 BUPHENYL R 57 Acute Decompensated Heart Failure 57 psoriasis inflammatory bowel 57 alemtuzumab Campath 57 leukemia lymphoma multiple myeloma 57 heFH 57 PrevOnco 57 Meets Primary Endpoint 57 polycythemia vera essential thrombocythemia 57 NCT# ClinicalTrials.gov 57 www.vicortech.com 57 metastatic renal cell 57 www.agennix.com 57 treat chronic sinusitis 57 multicenter Phase 57 lung esophageal 57 COSTAR II 57 visit www.silvercross.org 57 antibody MAb 57 refractory multiple myeloma 57 intravesical infusion therapy 57 2 methoxyestradiol 57 NMIBC 57 Folfox 57 Liprotamase 57 Arch Intern Med 57 CYT# vascular disrupting 57 lung pancreatic 57 PET FROM 57 smoldering myeloma 57 http:/www.BMRN.com 57 vinorelbine tartrate 57 Poly ICLC 57 www.questcor.com 57 develop HBV reactivation 57 MERLIN TIMI 57 Cimzia TM 57 visit www.rtanswers.org 57 Mg Usa 57 HBeAg negative patients 57 alpha1 antitrypsin deficiency 57 ADVERSE EVENTS 57 Phase #b/#a 57 Reports Preclinical Data 57 multicenter Phase II 57 PERSEUS 57 Initiate Clinical Trial 57 IMPDH inhibitor 57 systemic invasive fungal 57 Aplidin R 56 STRIDE PD 56 MIST II 56 www.avigen.com 56 metastatic gastric 56 Chronic Lymphocytic Leukemia CLL 56 triggers apoptosis programmed 56 Zemplar Capsules 56 By JENNIFER LEARN 56 subcutaneous PRO 56 PDE# inhibitors 56 vivo toxicology 56 www.vioquestpharm.com 56 psoriasis rheumatoid arthritis 56 QNEXA ® 56 Edge STudy 56 MEND CABG 56 romidepsin 56 PROTECT AF 56 thorough QT 56 Threat eBook 56 Provectus Pharmaceuticals specializes 56 Callisto initiated 56 psoriatic arthritis PsA 56 www.achillion.com 56 brivaracetam 56 TKB# 56 ENDEAVOR III 56 CEQ# 56 www.TradeTheTrend.com 56 intrahepatic bile duct 56 Phase IIa trials 56 please visit www.anci 56 exocrine pancreatic insufficiency EPI 56 NSABP B 56 e antigen HBeAg 56 www.baxa.com 56 call #.#.NEXAVAR #.#.#.# 56 Medullary Thyroid Cancer 56 baminercept 56 pediatric pontine glioma 56 Randomized Double blind 56 www.nymox.com email info@nymox.com 56 elacytarabine 56 oxymorphone ER 56 virus HCV protease inhibitor 56 plus prednisone prednisolone 56 Initiated Phase 56 Patient Enrollment 56 TNFerade TM 56 R rosiglitazone maleate 56 PROSTVAC VF 56 www.gpc biotech.com 56 deep venous thromboses 56 Angiotensin Therapeutic Vaccine 56 www.polaris int.com 56 event visit www.zenithinfotech.com 56 HCV polymerase 56 sulfonylurea glimepiride 56 http:/www.atherogenics.com 56 IG HCR ;) CO 56 AERx ® 56 chronic idiopathic thrombocytopenic purpura 56 randomized controlled Phase 56 metastatic HRPC 56 Clevudine 56 dirucotide MBP# 56 http:/www.celgene.com 56 Panzem NCD 56 PRESEPT 56 pain palliation 56 docetaxel Taxotere ® 56 Xanafide 56 Pharmacokinetics PK 56 Drug Eluting Stent System 56 relapsed mantle 56 Selective Electrochemical Tumor Ablation 56 steroid refractory GvHD 56 Demonstrates Positive 56 Nasdaq PPHM 56 See CLINICAL PHARMACOLOGY 56 cisplatin gemcitabine 56 Demonstrates Significant 56 http:/www.icislor.com/dram/index.htm 56 fusion enhancers 56 XL# XL# 56 recurrent NSCLC 56 Tanespimycin 56 IL# PE#QQR 56 NASDAQ CXSP announced 56 Fovea Pharmaceuticals subsidiary 56 dependent kinase inhibitor 56 Darinaparsin 56 T1c 56 http:/www.vical.com 56 LPLD 56 sunitinib malate 56 ANN INTERN MED 56 PROSTASCINT R 56 evaluating MGCD# [002] 56 TransVax 56 patients coinfected 56 HQK 56 RhuDex ® 56 metastatic colorectal 56 VNP#M 56 LHRH receptor positive 56 oral picoplatin 56 gastrointestinal stromal tumors GIST 56 Annamycin 56 APEX AMI 56 MKC# 56 Parathyroid Hormone 56 www.hceda.org thecenter 56 aggressive systemic mastocytosis 56 MBRX 56 MGd 56 www.stemcellsinc.com 56 Phase IIb Trial 56 MYCAMINE 56 GARDASIL ® 56 OMP #R# 56 refractory Hodgkin 56 Naive Patients 56 vaso occlusive crises 56 phase IIa clinical 56 www.cougarbiotechnology.com 56 http:/www.marinabio.com 56 orally administered synthetic retinoid 56 www.acusphere.com 56 Calcium Acetate 56 Bezielle 56 COU AA 56 SNT-MC#/idebenone 56 non splenectomized 56 Refractory Hodgkin Lymphoma 56 selective A2A adenosine receptor 56 HoFH 56 www.criticaloutcome.com 56 www.chembio.com 56 unresectable HCC 56 Vicinium TM 56 Diamyd r 56 autoimmune disorders asthma 56 TELINTRA R 56 non cirrhotic portal 56 http:/www.reprosrx.com 56 VISICOL R 56 recurrent bladder 56 TRA 2P 56 Vitaxin 56 www.delcath.com 56 gastrointestinal stromal tumors GISTs 56 tuberous sclerosis TS 56 By JAMAAL ABDUL 56 Bystolic nebivolol 56 SUTENT ® 56 StemEx 56 neutropenic sepsis 56 LAB CGRP 56 follicular Non Hodgkin 56 Xyfid TM 56 drug figitumumab 56 Omacetaxine 56 miconazole Lauriad ® 56 placebo controlled Phase 56 Phase 2b Trial 56 Novel Oral 56 www.pranabio.com 55 beta 1a 55 http:/www.pharmacopeia.com 55 novel oral anticoagulant 55 http:/www.JazzPharmaceuticals.com 55 TBC# 55 REVIVE TA 55 leukemia AML 55 treating sarcoma testicular 55 www.med 55 Salix Pharmaceuticals Announces 55 RSR# 55 Pivotal Trial 55 mitoxantrone plus 55 Hormone Refractory Prostate Cancer 55 2 inhibitor CYT# 55 Postdoctoral Position 55 NDA Submission 55 Systemic Sclerosis 55 Acute Myeloid Leukaemia AML 55 FOLFOX6 chemotherapy regimen 55 Kinesin Spindle Protein KSP 55 Biogen Genentech 55 register.php 55 Prestara 55 Albuferon albinterferon alfa 2b 55 im peramivir 55 Allovectin 7 55 SILENOR TM doxepin HCl 55 www.sanofi aventis.com 55 Phase 1a clinical 55 Twinrix 55 Metastatic Melanoma 55 www.resverlogix.com 55 Intravenous immunoglobulin 55 TNFerade ™ 55 thalidomide Thalomid 55 non hodgkin lymphoma 55 Investigational Drug 55 CB2 selective receptor agonist 55 THR beta agonist 55 gastrin analogue TT 55 Amrubicin 55 HepeX B 55 Accessed #/#/# [001] 55 tanespimycin 55 OVATURE trial 55 Trovax 55 Phase 2b kidney transplant 55 Prolongs Survival 55 chronic eosinophilic leukemia 55 Phase 2a clinical trials 55 Septin9 biomarker 55 hyperphenylalaninemia HPA due 55 Advaxis Phase 55 ® lenalidomide 55 BARACLUDE ® 55 TNF antagonist 55 chronic HBV 55 histologic subtype 55 www.osteologix.com 55 Vidaza ® 55 RhuDex 55 regorafenib 55 www.communityed#.org 55 Fabry Disease 55 Personalized Immunotherapy 55 CALGB 55 MKC# MKC# PP 55 www.aryx.com 55 R# #mg BID 55 dexanabinol 55 www.celsion.com 55 Aflibercept 55 TELCYTA 55 Liposomal Grb 2 55 riociguat 55 hepatitis B immune globulin 55 Bafetinib 55 genomic biomarker 55 DMFs globally 55 www.vical.com 55 autoantibody positive 55 CATIE AD 55 Copegus ® 55 pemphigus vulgaris 55 PNP inhibitor 55 www.ingenuity.com 55 TO AVOID PREGNANCY WHILE 55 metastatic malignant 55 certolizumab 55 Augment ™ 55 drug Treanda 55 HBeAg + 55 trastuzumab Herceptin ® 55 docetaxel Taxotere R 55 acute myeloid 55 Receives CE Marking 55 ENESTnd 55 Seliciclib 55 receiving immunosuppressive therapy 55 GSK cervical cancer 55 www.cominar.com 55 Onalta TM 55 XOMA 3AB 55 relapsing multiple sclerosis 55 TRISENOX ® 55 Tarvacin Anti Cancer 55 Multiple Ascending Dose 55 multicenter multinational 55 http:/www.clinicaltrials.gov/ 55 Lymphocytic 55 http:/www.npsp.com 55 lymphoid malignancies 55 gastro intestinal inflammation 55 CYP#A# CYP#D# 55 IN PATIENTS WITH 55 H#N# VLP 55 manufactures minimally invasive 55 TYGACIL 55 AIR CF1 55 pivotal bioequivalence 55 http:/www.gene.com/ 55 oral prodrug 55 KIACTA ™ 55 Tovaxin TM 55 TRO# 55 Sudhir Agrawal D.Phil 55 NO# [002] 55 investigational hepatitis B 55 prelicensure 55 Chronic lymphocytic leukemia 55 www.hematology.org 55 vaccine Stimuvax 55 Renal Cell Carcinoma RCC 55 genotypic resistance 55 Allovectin 7 ® 55 Pivotal Phase 55 refractory indolent non 55 Daclizumab 55 J Am Coll 55 investigational protease inhibitor 55 Cellceutix web 55 www.roche 55 PRESEPT study 55 Diabetic Neuropathy 55 Asentar 55 CIMZIA TM 55 taxane chemotherapy administered 55 Onglyza saxagliptin 55 ug dose 55 lymphomas leukemias 55 Call Bette Antonellis 55 cSSSIs 55 oral salmon calcitonin 55 immunotherapeutic approaches 55 Depressed bipolar 55 cause mesothelioma asbestosis 55 anti atherothrombotic 55 receiving XGEVA 55 Phase IIb Clinical Trial 55 Sapacitabine 55 double blinded placebo 55 www.pbmi.com 55 HCD# [002] 55 www.juneau.org parksrec adult 55 www.ewomennetwork.com 55 lomitapide 55 Adjuvant Treatment 55 estrogen receptor beta agonist 55 treating chronic myeloid 55 rheumatoid arthritis osteoarthritis ankylosing 55 sargramostim 55 CIMZIA ™ 55 #-# Full Text 55 www.bio rad.com 55 TAXUS ARRIVE 55 glucocorticoid induced osteoporosis 55 Fludara ® 55 Cancer Incidence Mortality 55 call Oveda Slade 55 5q MDS 55 BARACLUDE R 55 #-#-# http:/botanicalgarden.berkeley.edu 55 #mg ATC 55 ganetespib 55 Pivotal Study 55 vidofludimus 55 SPL# Gel vaginal microbicide 55 ADAGEN 55 GAMMAGARD 54 Active Ulcerative Colitis 54 eritoran 54 HDAC Inhibitor 54 M# rationally 54 teriflunomide 54 ABSSSI 54 Vaccine Adjuvant 54 PRIMO CABG 54 Phase Ib clinical trials 54 VELCADE melphalan 54 occlusion PAO 54 http:/www.orexigen.com 54 HIV HCV coinfected 54 Peginterferon Alfa 2a 54 DAPT Study 54 visit www.sanofi aventis.us 54 phase IIa 54 idiotype vaccines 54 sulfonylurea metformin 54 telomerase inhibitor drug 54 http:/www.bmpsunstone.com 54 EGFR HER2 54 Toremifene 54 First Patient Enrolled 54 visit www.marrow.org 54 Risperidone Oral Solution 54 fidaxomicin Phase 54 GigaMedia Limited Singapore 54 www.lonza.com 54 Teriflunomide 54 AA Amyloidosis 54 cell lymphoma CTCL 54 bendamustine ifosfamide 54 HCV RESPOND 2 54 Stage IIB 54 dose escalation clinical 54 www.rideSTA.com 54 pediatric acute lymphoblastic 54 Presents Preclinical 54 previously untreated follicular 54 randomized discontinuation trial 54 unresectable stage 54 DCVax R 54 Anti Factor VIII 54 VICTOR E1 54 Gleevec Glivec 54 www.frankbettecenter.org 54 Randomized Double Blind 54 immunotherapeutic vaccine 54 multiple myeloma MM 54 Hodgkin lymphoma HL 54 Am J Epidemiol 54 trastuzumab emtansine T DM1 54 relapsed acute lymphoblastic 54 BCIRG 54 peritumoral brain edema 54 Fibrin Pad 54 lenalidomide Revlimid R 54 TG MV 54 Inc. Nasdaq SGXP 54 clinical trials Archexin 54 www.cancerconsultants.com 54 email sbarnes@novaknowledge.ns.ca 54 Cetrorelix pamoate 54 brand ciclesonide HFA 54 rhLF 54 Nipent R 54 ELACYT 54 Obatoclax 54 Hepatotoxicity 54 adult chronic ITP 54 neurogenic orthostatic hypotension NOH 54 Interferon beta 1b 54 basal cell carcinoma BCC 54 www.cticseattle.com 54 ® bortezomib